NASDAQ Companies

Continued execution against operational improvement goals helps to offset softer rate environment and puts Company in position to exit pandemic […]

$40.3 million revenue$5.0 million net income$17.8 million EBITDANo significant debt maturities until 2023MONACO, May 07, 2020 (GLOBE NEWSWIRE) — Navios […]

RAMSEY, N.J. and BOCA RATON, Fla., May 07, 2020 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end […]

NEW YORK, May 07, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development […]

— Commercial preparations advancing, with topline PEDFIC 1 results expected mid-2020  —— First sites initiated for second pivotal trial in […]

– Topline data announcement from the ongoing head-to-head COMPARE trial of SEL-212 remains on schedule for Q3 2020 –– Phase […]

OV101 met the study’s primary objective of safety and tolerabilityOV101 produced statistically significant reductions in behavioral and functional symptoms in […]

Option to license an additional five programs for a total of seventeenExtended option and research term to allow for collaboration […]

Pending Merger with Lantheus Holdings, Inc. for Combination of an Innovative Commercial Life Sciences Company with a Diversified Precision Diagnostics […]

SAN DIEGO, May 07, 2020 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing […]